-
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Study
EGAS00001003953
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000812
-
Targeting the DNA Repair Pathway in Ewing Sarcoma
Study
EGAS00001000839
-
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Study
EGAS00001001002
-
Deep_sequencing_of_melanoma_for_driver_mutations
Study
EGAS00001000857
-
Phenotypic_characterisation_of_LRRN4CL_over_expression
Study
EGAS00001003976
-
Cross-species genomics identifies TAF12, NFYC and RAD54L as novel choroid plexus carcinoma oncogenes
Study
EGAS00001000961
-
Comprehensive miRNA Sequence Analysis Reveals Survival Differences in Diffuse Large B-cell Lymphoma Patients
Study
EGAS00001001025
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Study
EGAS00001004015
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Deciphering the mutational landscape and the genome organization of LMS
Study
EGAS00001001262
-
Precursor_lesions__clonal_architecture_and_relapse_in_Wilms_nephroblastoma
Study
EGAS00001001422
-
RNA_expression_profiling_of_melanoma_patient_derived_xenograft
Study
EGAS00001001537
-
Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study
Study
EGAS00001001709
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
Integrated Molecular Profilting in Advanced Cancers Trial
Study
EGAS00001001897
-
Patients with metastatic urothelial carcinoma
Study
EGAS00001002114
-
Integrative_Oncogenomics_of_Multiple_Myeloma
Study
EGAS00001000036
-
The genomic landscape of Burkitt Lymphoma
Study
EGAS00001002198
-
The Immune Microenvironment, Genome–Wide Copy Number Aberrations and Survival in Mesothelioma
Study
EGAS00001002323
-
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
Study
EGAS00001003408
-
ICGC Oesophageal adenocarcinoma - 100 tumour samples
Study
EGAS00001000724
-
Osteosarcoma_Exome_Sequencing
Study
EGAS00001000163
-
Chondrosarcoma_Validation_Study
Study
EGAS00001000181
-
Exome-sequencing identifies new oncogenes and tumor suppressor genes recurrently altered in hepatocellular carcinoma
Study
EGAS00001000217
-
Whole-genome and transcriptome sequencing of tumor-stage mycosis fungoides
Study
EGAS00001002860
-
Targeted_gene_fusion_sequencing__Fus_seq__in_mesothelioma
Study
EGAS00001000390
-
Chondrosarcoma_Targeted_Sequencing_Study
Study
EGAS00001000277
-
Recurrent Somatic Mutations of PTPN1 in Primary Mediastinal B cell lymphoma and Hodgkin Lymphoma
Study
EGAS00001000554
-
Hypermutation of the inactive X chromosome is a frequent event in cancer
Study
EGAS00001000565
-
RB1 Gene Inactivation by Chromothripsis in Human Retinoblastoma
Study
EGAS00001000598
-
Identification_of_drug_resistance_genes_in_melanoma
Study
EGAS00001000617
-
Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue
Study
EGAS00001000737
-
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Study
EGAS00001001024
-
RNAseq___Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000813
-
Genomic landscape of Ewing sarcoma (ICGC project)
Study
EGAS00001000855
-
The Genomic Landscape of Childhood and Adolescent Melanoma
Study
EGAS00001000901
-
Whole genome study of Hurthle cell thyroid carcinoma
Study
EGAS00001000940
-
Whole exome sequencing of peripheral T-cell lymphoma (PTCL)
Study
EGAS00001000557
-
Onco-exaptation of an Endogenous Retroviral LTR Drives IRF5 Expression in Hodgkin Lymphoma
Study
EGAS00001001205
-
DIPG RNA and exome sequencing
Study
EGAS00001004749
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
Volasertib preclinical activity in high-risk hepatoblastoma
Study
EGAS00001004827
-
Whole genome sequencing of metastatic melanomas from a patient with primary resistance to BRAF inhibition
Study
EGAS00001000580
-
A genome-wide association study for nasopharyngeal carcinoma in Hong Kong population
Study
EGAS00001006102
-
ICGC Oesophageal adenocarcinoma - lymph-node samples
Study
EGAS00001000727
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580
Study
EGAS00001007466
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
A MITF germline mutation predisposes to melanoma and renal cell carcinoma
Study
EGAS00000000048
-
Tumor-associated preferred end coordinates and somatic variants as signatures of circulating tumor DNA
Study
EGAS00001003160
-
Leiomyosarcoma Data Access Committee
Dac
EGAC00001000415
-
Pediatric HGG WES and RNA-Seq
Study
EGAS00001005687
-
Validation of a targeted sequencing panel for multiple myeloma
Study
EGAS00001006164
-
Intra-tumor heterogeneity and clonal evolution patterns towards platinum-resistant high-grade serous ovarian cancer
Study
EGAS00001001244
-
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
Study
EGAS00001001281
-
ATRX mutant neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal differentiation.
Study
EGAS00001002507
-
Whole Genome Sequencing of Neuroblastoma
Study
EGAS00001000222
-
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Study
EGAS00001001479
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Germline and somatic SMARCA4 mutations characterize small-cell carcinoma of the ovary, hypercalcemic type.
Study
EGAS00001000721
-
Spatial heterogeneity in medulloblastoma
Study
EGAS00001001014
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
VIKING Health Study - Shetland
Study
EGAS00001003872
-
CD74-NRG1 fusions in lung adenocarcinoma
Study
EGAS00001000653
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
Transcriptome sequencing of intravenous leiomyomatosis and uterine myoma
Study
EGAS00001002504
-
STAT5 is a therapeutically targetable vulnerability in cutaneous T-cell lymphoma
Study
EGAS00001004719
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Study
EGAS00001000369
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Study
EGAS00001000399
-
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Study
EGAS00001001190
-
Genomic Profiling Reveals Spatial Intra-tumour Heterogeneity in Follicular Lymphoma
Study
EGAS00001002492
-
Whole genome sequencing, SNP array and RNA-seq of uveal melanomas
Study
EGAS00001000472
-
Whole Exome Sequencing of cohorts of Mutant Braf mouse model melanoma DNA and germline DNA.
Study
EGAS00001000729
-
Whole genome sequencing of acral melanomas
Study
EGAS00001000486
-
Whole genome sequencing and whole exome sequencing of mucosal melanoma
Study
EGAS00001000474
-
Ultraviolet radiation drives mutations in a subset of mucosal melanomas
Study
EGAS00001004697
-
The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
Study
EGAS00001005201
-
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup
Study
EGAS00001001000
-
Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation
Study
EGAS00001002796
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Study
EGAS00001000510
-
Blueprint RNAseq profile of purified plasma cells from multiple myeloma patients and tonsils of healthy donors
Study
EGAS00001001110
-
BLUEPRINT Bisulfite-seq and Whole Genome Sequencing of mantle cell lymphoma
Study
EGAS00001001638
-
HumanMethylation450K data from Purified Plasma Cells of Monoclonal gammopathy of unknown significance and Multiple myeloma patients and Healthy donors
Study
EGAS00001000841
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Study
EGAS00001000579
-
Sampling of multi-centric lower grade glioma influences management and provides insight into gliomagenesis
Study
EGAS00001002495
-
Recurrent epimutations activate gene body promoters in primary glioblastoma
Study
EGAS00001000685
-
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
Study
EGAS00001001179
-
Inhibiton of the GABPB1L-containing GABP tetramer is sufficient to reverse replicative immortality in TERT promoter mutant glioblastoma cells.
Study
EGAS00001002582
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma
Study
EGAS00001000662
-
Frequent alterations in cytoskeleton remodeling genes in primary and metastatic Chinese lung adenocarcinomas
Study
EGAS00001000982